📢 New Prospective Long-Term Study Highlights the Power of Genomics in Reducing Heart Attacks and Coronary Events 🧬
A recent 10-year study reveals that using genomics, specifically polygenic risk scores (PRS), can significantly reduce heart attacks and major cardiac events, leading to improved patient outcomes.
The study found that patients aware of their PRS experienced 77% fewer major adverse cardiovascular events (MACE) and a 39% reduction in diagnostic testing for coronary heart disease (CHD).
This underscores the incredible potential of genomics in healthcare.
With OpenDNA, one of our portfolio companies, its advanced cloud-based precision genomic medicine platform uses AI to predict risks and personalize treatments, leading to improved patient outcomes and reduced healthcare costs.
🚀 This is not the future; it’s already here! 🚀
Read the eMerge Study here > https://www.medrxiv.org/content/10.1101/2024.07.19.24310709v1
Join OpenDNA as investor at>> https://s.pipelbiz.com/zsgBkE
#GenomicMedicine #CardiovascularHealth #PrecisionMedicine #HealthcareInnovation
We couldn’t be prouder of our portfolio company Blink Energy for successfully completing a proof of concept project on the world’s first eyelid biomarker!
This biomarker, which is monitoring Blink Energy's CEO Yariv Bar-on’s blinking patterns in the video, opens up groundbreaking possibilities and can be leveraged for many market applications, ranging from biomedicine (e.g., dry eye syndrome) to cognition (e.g., Epilepsy seizure alarm) and safety (e.g., workplace fatigue).
Learn more >>https://www.blinkenrg.com/
#innovation #ophthalmology #healthcare #biomarkers
Today, on the International Day of Women and Girls in Science, let's address the vital need for more female representation in the field of medicine, particularly in light of shocking revelations like period products were tested with actual blood for the first time ever in 2023 (Yes, you read that right, 2023!) >> https://www.thepinknews.com/2023/08/18/period-products-blood-test-first-time/
This highlights just how far we still need to go when it comes to women's health, and why we need to have more Women and Girls in Science!
At MindUP the Digital Health Incubator, we're proud to support innovative companies like Nevia bio and DermAb.io, who are revolutionizing women's healthcare >> https://lnkd.in/daKzyf2
Nevia bio focuses on early disease detection through vaginal secretions analysis, empowering women to take control of their health. DermAb.io is developing a smarter platform for precision medicine in chronic & autoimmune diseases, which overwhelmingly afflict women.
Let's champion female-led innovation and pave the way for a healthier future for all women! Take a look on what Miriam Oron Ph.D. and Meital Portugal, PhD had to say >>
#WomenInHealth #HealthcareInnovation
With a great team and technology, this company is one to watch - BLINK ENERGY!
As they turn their vision into reality, we're proud to support them and The Blink Patch - The First-of-its-Kind Multi Sensor Patch for Real-Time Monitoring of Eye Movements, Blinking Dynamics, and Physiological Signals!
Learn more > https://www.blinkenrg.com/
#ophthalmology #innovation #digitalhealth
MindUP, Haifa's Digital Health Incubator is a venture of Medtronic, IBM, Pitango Venture Capital, Impact 1st Investments and Rambam Medical Center.
